Accelerated Assessment Success In EU For CSL Behring And Roche

EtranaDez Will Be And Mosunetuzumab Already Is On Fast-Track Review Pathway At EMA

 
• By Maureen Kenny
  
Investigational hemophilia B gene therapy EtranaDez has received EU fast track status • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards